{"context":{"query":">>mondo>>gwas","source_dataset":"mondo","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]MONDO:0011962,73,MONDO:0011962,97,0]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"MONDO:0011962","source":"MONDO:0011962|endometrial cancer","targets":["GCST90296493_1|Endometrial cancer or COVID-19 infection (pleiotropy)|BCL11A|2|2.000000e-08","GCST90296493_2|Endometrial cancer or COVID-19 infection (pleiotropy)|ABO|9|3.000000e-85","GCST90296494_1|Endometrial cancer or hospitalized COVID-19 (pleiotropy)|BCL11A|2|1.000000e-11","GCST90296494_2|Endometrial cancer or hospitalized COVID-19 (pleiotropy)|MIR4713HG, CYP19A1|15|3.000000e-14","GCST90296494_3|Endometrial cancer or hospitalized COVID-19 (pleiotropy)|ABO|9|4.000000e-26","GCST90296495_1|Endometrial cancer or critical COVID-19 (pleiotropy)|BCL11A|2|5.000000e-12","GCST90296495_2|Endometrial cancer or critical COVID-19 (pleiotropy)|ABO|9|4.000000e-13","GCST90308764_1|Cancer|TRIM46|1|4.000000e-08","GCST90308764_10|Cancer|TESHL|2|2.000000e-10","GCST90308764_11|Cancer|PELO-AS1|5|1.000000e-08","GCST90308764_12|Cancer|CCDC170 - ESR1|6|3.000000e-09","GCST90308764_13|Cancer|HLA-DQB1|6|2.000000e-15","GCST90308764_14|Cancer|Y_RNA - AZGP1|7|3.000000e-09","GCST90308764_15|Cancer|PCAT1, CASC8, POU5F1B|8|9.000000e-29","GCST90308764_16|Cancer|PSCA - LY6K|8|3.000000e-12","GCST90308764_17|Cancer|CHCHD4P2 - RPL36P14|9|6.000000e-09","GCST90308764_18|Cancer|CDKN2B-AS1|9|6.000000e-11","GCST90308764_19|Cancer|STN1 - SLK|10|8.000000e-10","GCST90308764_2|Cancer|KCNQ1|11|5.000000e-09","GCST90308764_20|Cancer|FGFR2|10|1.000000e-21","GCST90308764_21|Cancer|RPL23AP61|10|2.000000e-10","GCST90308764_22|Cancer|KIF20B - MTND5P42|10|3.000000e-08","GCST90308764_23|Cancer|POU2AF3, COLCA1|11|2.000000e-09","GCST90308764_3|Cancer|LINC01488|11|8.000000e-14","GCST90308764_4|Cancer|RCCD1|15|1.000000e-08","GCST90308764_5|Cancer|TOX3|16|7.000000e-17","GCST90308764_6|Cancer|HNF1B|17|3.000000e-21","GCST90308764_7|Cancer|CASC17|17|8.000000e-10","GCST90308764_8|Cancer|SMAD7|18|2.000000e-08","GCST90308764_9|Cancer|LINC01101 - Y_RNA|2|9.000000e-09","GCST90454186_1|Endometrial cancer|BCL11A|2|7.000000e-10","GCST90454186_10|Endometrial cancer|SSPN, SSPN-AS1|12|1.000000e-11","GCST90454186_11|Endometrial cancer|SH2B3|12|3.000000e-12","GCST90454186_12|Endometrial cancer|TBX3-AS1 - UBA52P7|12|3.000000e-09","GCST90454186_13|Endometrial cancer|RNY1P8 - MARK2P12|13|1.000000e-19","GCST90454186_14|Endometrial cancer|SRP14-DT|15|4.000000e-12","GCST90454186_15|Endometrial cancer|MIR4713HG, CYP19A1|15|2.000000e-18","GCST90454186_16|Endometrial cancer|HNF1B|17|2.000000e-23","GCST90454186_17|Endometrial cancer|SNX11 - SKAP1|17|5.000000e-11","GCST90454186_18|Endometrial cancer|LINC00824|8|7.000000e-06","GCST90454186_19|Endometrial cancer|NF1, EVI2A|17|7.000000e-07","GCST90454186_2|Endometrial cancer|RN7SL361P - IFITM3P9|2|3.000000e-11","GCST90454186_3|Endometrial cancer|BOLA2P3 - CASC15|6|9.000000e-28","GCST90454186_4|Endometrial cancer|HEY2-AS1, LINC02523|6|4.000000e-16","GCST90454186_5|Endometrial cancer|PVT1 - RN7SKP226|8|5.000000e-09","GCST90454186_6|Endometrial cancer|LINC00824 - CCDC26|8|5.000000e-13","GCST90454186_7|Endometrial cancer|LINC00824 - CCDC26|8|3.000000e-09","GCST90454186_8|Endometrial cancer|CDKN2B-AS1 - DMRTA1|9|3.000000e-09","GCST90454186_9|Endometrial cancer|WT1-AS|11|4.000000e-08","GCST90651044_1|Endometrial cancer|CYP19A1, MIR4713HG|15|2.000000e-12","GCST90651044_2|Endometrial cancer|BOLA2P3 - CASC15|6|4.000000e-07","GCST90651054_1|Cancer|LINC01661 - PRMT6|1|2.000000e-08","GCST90651054_10|Cancer|MRTFA|22|3.000000e-08","GCST90651054_11|Cancer|C5orf67 - MAP3K1|5|7.000000e-09","GCST90651054_12|Cancer|LINC-PINT|7|3.000000e-09","GCST90651054_13|Cancer|PCAT1, CASC8, POU5F1B|8|6.000000e-22","GCST90651054_14|Cancer|CHCHD4P2 - RPL36P14|9|2.000000e-09","GCST90651054_2|Cancer|STN1|10|1.000000e-10","GCST90651054_3|Cancer|FGFR2|10|1.000000e-25","GCST90651054_4|Cancer|RPL23AP61|10|7.000000e-10","GCST90651054_5|Cancer|LINC01488 - PNCRNA-D|11|1.000000e-15","GCST90651054_6|Cancer|TOX3|16|2.000000e-17","GCST90651054_7|Cancer|HNF1B|17|1.000000e-14","GCST90651054_8|Cancer|TESHL|2|6.000000e-10","GCST90651054_9|Cancer|LINC03086 - TGM3|20|4.000000e-08","GCST90651069_1|Cancer|IGF2BP2|3|2.000000e-08","GCST90651069_2|Cancer|TTC33|5|2.000000e-08","GCST90651069_3|Cancer|PELO-AS1|5|2.000000e-08","GCST90651069_4|Cancer|HLA-DQB1|6|2.000000e-13","GCST90651069_5|Cancer|PCAT1, PRNCR1, CASC19|8|2.000000e-15","GCST90651069_6|Cancer|PSCA, JRK|8|3.000000e-13","GCST90651069_7|Cancer|GBA1LP, GBA1LP|1|1.000000e-10","GCST90651069_8|Cancer|HNF1B|17|2.000000e-08","GCST90693321_1|Body mass index or endometrial cancer (pleiotropy)|MAP2K5|15|3.000000e-10","GCST90693321_2|Body mass index or endometrial cancer (pleiotropy)|IQCK|16|1.000000e-09","GCST90693321_3|Body mass index or endometrial cancer (pleiotropy)|RAB11FIP4|17|9.000000e-09","GCST90693321_4|Body mass index or endometrial cancer (pleiotropy)|SKAP1|17|1.000000e-08","GCST90693321_5|Body mass index or endometrial cancer (pleiotropy)|BPTF|17|3.000000e-10","GCST90693321_6|Body mass index or endometrial cancer (pleiotropy)|DNAJC1|10|4.000000e-09","GCST90693321_7|Body mass index or endometrial cancer (pleiotropy)|HECTD4|12|3.000000e-10","GCST90693321_8|Body mass index or endometrial cancer (pleiotropy)|NRXN3|14|6.000000e-10","GCST90693326_1|Waist-to-hip ratio or endometrial cancer (pleiotropy)|BDNF-AS, BDNF|11|2.000000e-08","GCST90693326_2|Waist-to-hip ratio or endometrial cancer (pleiotropy)|SSPN-AS1, SSPN|12|3.000000e-15","GCST90693326_3|Waist-to-hip ratio or endometrial cancer (pleiotropy)|PSME3|17|3.000000e-09","GCST90693326_4|Waist-to-hip ratio or endometrial cancer (pleiotropy)|BPTF|17|4.000000e-11","GCST90693326_5|Waist-to-hip ratio or endometrial cancer (pleiotropy)|PPARG|3|5.000000e-13","GCST90693326_6|Waist-to-hip ratio or endometrial cancer (pleiotropy)|HEY2-AS1, LINC02523|6|8.000000e-11","GCST90693326_7|Waist-to-hip ratio or endometrial cancer (pleiotropy)|MLXIPL - VPS37D|7|2.000000e-11","GCST90693326_8|Waist-to-hip ratio or endometrial cancer (pleiotropy)|ZKSCAN5|7|3.000000e-08","GCST90693330_1|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|SSPN-AS1, SSPN|12|2.000000e-18","GCST90693330_10|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|LINC01556|6|2.000000e-08","GCST90693330_11|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|TRMT11|6|8.000000e-11","GCST90693330_12|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|LINC00824 - CCDC26|8|1.000000e-09","GCST90693330_2|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|RFLNA|12|2.000000e-09","GCST90693330_3|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|SRP14-DT|15|2.000000e-08","GCST90693330_4|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|MIR4713HG, CYP19A1|15|3.000000e-10","GCST90693330_5|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|RAB11FIP4|17|4.000000e-09","GCST90693330_6|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|HNF1B|17|2.000000e-10","GCST90693330_7|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|PSME3|17|2.000000e-10","GCST90693330_8|Waist-to-hip ratio adjusted for body mass index or endometrial cancer (pleiotropy)|BPTF|17|5.000000e-08"]}]}